Schonfeld Strategic Advisors LLC Acquires New Stake in Option Care Health, Inc. (NASDAQ:OPCH)

Schonfeld Strategic Advisors LLC bought a new position in Option Care Health, Inc. (NASDAQ:OPCH) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 22,992 shares of the company’s stock, valued at approximately $533,000.

A number of other large investors have also made changes to their positions in OPCH. Murphy & Mullick Capital Management Corp bought a new position in shares of Option Care Health in the 4th quarter worth approximately $26,000. UMB Bank n.a. increased its holdings in Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after buying an additional 346 shares during the last quarter. Signaturefd LLC raised its position in Option Care Health by 487.9% in the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock worth $28,000 after acquiring an additional 1,005 shares during the period. Quadrant Capital Group LLC boosted its stake in shares of Option Care Health by 172.8% during the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company’s stock worth $40,000 after acquiring an additional 1,099 shares during the last quarter. Finally, Johnson Financial Group Inc. bought a new stake in shares of Option Care Health during the 4th quarter valued at $47,000. 98.05% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on OPCH shares. Barrington Research reiterated an “outperform” rating and set a $38.00 target price on shares of Option Care Health in a research report on Wednesday, April 30th. JPMorgan Chase & Co. boosted their price objective on Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research note on Thursday, March 6th. Jefferies Financial Group upgraded shares of Option Care Health from a “hold” rating to a “buy” rating and raised their target price for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. UBS Group upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and upped their price target for the stock from $38.00 to $40.00 in a research report on Wednesday, April 30th. Finally, Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and raised their price objective for the company from $26.00 to $33.00 in a research report on Monday, January 13th. One equities research analyst has rated the stock with a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $35.50.

Insider Activity at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the transaction, the insider now directly owns 44,974 shares of the company’s stock, valued at $1,495,835.24. This trade represents a 40.80 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. 0.64% of the stock is owned by insiders.

Option Care Health Stock Up 0.4 %

Shares of OPCH stock opened at $31.84 on Friday. The company’s fifty day simple moving average is $33.24 and its two-hundred day simple moving average is $28.89. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53. The stock has a market cap of $5.21 billion, a P/E ratio of 26.76, a PEG ratio of 2.30 and a beta of 0.76. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.36 by $0.04. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The company had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.26 billion. During the same period in the prior year, the company earned $0.26 earnings per share. The firm’s revenue was up 16.3% on a year-over-year basis. Analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.